Engineering aptamer-based therapeutics for precision cancer immunotherapy: from molecular targeting to clinical applications.

Azhar MA, Ahmed S, Altuhami A, Shabab M, Assiri AM, Broering DC, Mir TA

DOI: 10.3389/fphar.2026.1987479
Published: 2026
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1987479,
  title = {Engineering aptamer-based therapeutics for precision cancer immunotherapy: from molecular targeting to clinical applications.},
  author = {Azhar MA and Ahmed S and Altuhami A and Shabab M and Assiri AM and Broering DC and Mir TA},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1987479},
  url = {https://doi.org/10.3389/fphar.2026.1987479}
}

RIS

TY  - JOUR
TI  - Engineering aptamer-based therapeutics for precision cancer immunotherapy: from molecular targeting to clinical applications.
AU  - Azhar MA
AU  - Ahmed S
AU  - Altuhami A
AU  - Shabab M
AU  - Assiri AM
AU  - Broering DC
AU  - Mir TA
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1987479
UR  - https://doi.org/10.3389/fphar.2026.1987479
ER  -

APA

MA, A., S, A., A, A., M, S., AM, A., DC, B., & TA, M. (2026). Engineering aptamer-based therapeutics for precision cancer immunotherapy: from molecular targeting to clinical applications.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1987479

Source records

pubmed · retrieved 2026-11-10T18:04:13.553Z